Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
Non-small cell lung cancer is recognized as the deadliest cancer across the globe. In some areas, it is more common in women than even breast and cervical cancer. Its rise, vaulted by smoking habits and increasing air pollution, has garnered much attention and resource in the medical field. The firs...
Enregistré dans:
Auteurs principaux: | Wenxiao Jiang, Guiqing Cai, Peter Hu, Yue Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8201e3885f3f42649a3d9af8a4a8c852 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical applications of pharmacogenomics
par: Quiñones,Luis, et autres
Publié: (2017) -
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
par: Michelle Liu, et autres
Publié: (2021) -
The pharmacogenomics journal
Publié: (2001) -
Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
par: Venkatachalapathy P, et autres
Publié: (2021) -
Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
par: Damian Mojsak, et autres
Publié: (2021)